Canopy Growth Corp’s huge cash position could produce a surprise: GMP

His price target is roughly the same as the current price of the stock, but GMP Securities analyst Martin Landry thinks Canopy Growth Corp’s (TSX:WEED) huge treasure chest could lead to an upside surprise.

On June 15, WEED announced that it had upsized its previously announced offering of convertible senior notes due 2023 to $500-million, part of which management said would be earmarked for expansion.

Landry says an extra half billion dollars could end up producing a surprise or two.

“With the recent financing, Canopy’s cash balance is the largest of the industry sitting at ~$800m, an enviable position. Our target price is based on a DCF using: 1) an 8% discount rate, 2) a 28% share (25% previously) of the Canadian recreational market, and a 28% EBITDA margin (unchanged), and (3) a 3% terminal growth. While our return to target is low, it does not account for future potential capital deployment beyond announced expansion plans, something we would anticipate given the excess cash balance.”

In a research update to clients today, Landry maintained his “Buy” rating and one-year price target of $40.00 on Canopy Growth Corp, implying a return of 1.5 per cent at the time of publication.

Landry thinks Canopy will generate EBITDA of negative $30.3-million on revenue of $78.7-million in fiscal 2018. He expects those numbers will improve to EBITDA of positive $58.3-million on a topline of $382.3-million the following year.

The analyst today also addressed Canopy’s upcoming Q4, 2018 results. He expects fourth quarter revenue will come in at $23.7-million, in line with the street consensus of $24.0-million. Landry thinks revenue growth will be lower than in quarters past as the company builds inventory for the recreational market, and that operating expenses will continue to increase as the company expands globally. He summarized the key data points he will be looking at from Q4.

“1. Production costs. Over the last four quarters Canopy has been able to reduce its cost per gram before shipping and fulfillment from $1.46 to $1.03. We project this trend to continue as the company improves yields.

2. BC Tweed may weigh on gross margin. While costs to harvest and post-harvest costs are expected to decrease, this will likely be offset by ramp-up costs at BC Tweed and other facilities. Recall that COGS in Q3FY18 were impacted by $2.9m. This impact should be larger in Q4FY18 as BC Tweed entered into cultivation during the quarter with no associated revenues.

3. Selling prices. We have modeled selling prices $8.38/gram in Q4 up sequentially from Q3FY18 at $8.30/grams. The company’s product mix is expected to continue to shift to value added products. Discussion with industry participant point to a continued health market for B2B sales suggesting promotional activity may have slowed down as LPs try to build inventory.

4. Details on recreational stores. Canopy is building a retail network with a presence in Newfoundland, Manitoba and Saskatchewan. We will look for details on timing of store opening, start-up costs and expected revenue levels.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: weed
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

9 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

16 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

16 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

17 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago